Absorption of the latter metabolite is mediated by angiotensin converting enzyme 2 (ACE2), the primary receptor of SARS-CoV-2, and has been recognized as a marker of inflammation in severe COVID-19 cases (Takeshita and Yamamoto, 2022). This evidence concerns the gene ACE2 and COVID-19.